1. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial  The Lancet
  2. Virus evolution could undermine a COVID-19 vaccine – but this can be stopped  The Conversation US
  3. Sinovac's COVID-19 vaccine induces quick immune response - study  The Star Online
  4. Chinese coronavirus vaccine appears safe and induces immune response  Metro.co.uk
  5. Sinovac's COVID-19 vaccine induces quick immune response: Study  CNA
  6. View Full coverage on Google News

As viruses are transmitted from person to person they are constantly mutating and replicating. Could the SARS-CoV-2 virus evolve to evade the new vaccines that have just been developed?As viruses are transmitted from person to person they are constantly mutating and replicating. Could the SARS-CoV-2 virus evolve to evade the new vaccines that have just been developed?

Virus evolution could undermine a COVID-19 vaccine – but this can be stopped

Virus evolution could undermine a COVID-19 vaccine – but this can be stopped

News, analysis and comment from the Financial Times, the worldʼs leading global business publication

Subscribe to read | Financial Times

SINGAPORE/BEIJING (Reuters) - Sinovac Biotech's <SVA.O> experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.SINGAPORE/BEIJING (Reuters) - Sinovac Biotech's <SVA.O> experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.

Sinovac's COVID-19 vaccine induces quick immune response - study | The Star

Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in ...Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in ...

Sinovac's COVID-19 vaccine induces quick immune response: Study - CNA

The results, published on Tuesday in The Lancet Infectious Diseases Journal, add to the number of vaccine candidates under trial that have been found safe.The results, published on Tuesday in The Lancet Infectious Diseases Journal, add to the number of vaccine candidates under trial that have been found safe.

Chinese Covid-19 vaccine also found safe, induces immune response - world news - Hindustan Times

But the level of antibodies produced was lower than in people who had recovered from the disease.But the level of antibodies produced was lower than in people who had recovered from the disease.

Coronavirus: Sinovac COVID-19 vaccine triggers quick immune response | Newshub

Phase one and two trials of Coronavac suggest it is effective and induces a fast responsePhase one and two trials of Coronavac suggest it is effective and induces a fast response

Chinese Covid vaccine appears safe and provokes immune response, says study

According to preliminary results published in The Lancet Infectious Diseases, the vaccine appeared to be safe and well tolerated at all tested doses.According to preliminary results published in The Lancet Infectious Diseases, the vaccine appeared to be safe and well tolerated at all tested doses.

Chinese coronavirus vaccine appears safe and induces immune response | Metro News

The study comes hot on the heels of upbeat news this month from US drugmakers Pfizer and Moderna as well as Russia that showed their experimental vaccines were over 90% effective.CoronaVac and four other experimental vaccines developed in China are currently undergoing late-stage trialsThe study comes hot on the heels of upbeat news this month from US drugmakers Pfizer and Moderna as well as Russia that showed their experimental vaccines were over 90% effective.CoronaVac and four other experimental vaccines developed in China are currently undergoing late-stage trials

Sinovac's Covid-19 vaccine CoronaVac induces quick immune response: Study

SINGAPORE/BEIJING - Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday. SINGAPORE/BEIJING - Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.

Sinovac's COVID-19 vaccine induces quick immune response: study | ABS-CBN News

Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed Wednesday.Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed Wednesday.

Sinovac's COVID-19 Vaccine Induces Quick Immune Response | Newsmax.com